![DayBreakweely](/assets/images/logo.png)
IPIAD augments standard therapy for pancreatic ductal adenocarcinoma
![IPIAD augments standard therapy for pancreatic ductal adenocarcinoma](https://d2jx2rerrg6sh3.cloudfront.net/image-handler/picture/2018/7/Malignant_fluid_cytology%3b_Malignant_cells_of_adenocarcinoma_may_spread_to_fluid__-_David_Litman_M1_32ff074a59024fa8aa4ee1b098c2d57a-620x480.jpg)
A new research perspective was published in Oncoscience (Volume 11) on February 7, 2024, entitled, "IPIAD- an augmentation regimen added to standard treatment o...
A new research perspective was published in Oncoscience (Volume 11) on February 7, 2024, entitled, "IPIAD- an augmentation regimen added to standard treatment o...
Read More
Other Stories in Health
- Study links monoclonal B-cell lymphocytosis to elevated melanoma risk
- APDI provides $200,000 in grants to advance pediatric substance use disorder devices
- Teeth Oil Pulling: Which oil is best for whitening teeth
- Bats and birds in Madrid are top carriers of zoonotic pathogens, study reveals
- Excelsior Nurses: Any luck in CA?
- Nicole Kidman Wore the Elevated Blazer Trend Classically Chic People Are Wearing
- Any nurse re-entry training in Metro Manila?
- Dengue survivors have 55% higher risk of heart complications than COVID patients
- The Movie Thread